AzTrials
AzTrials

HealthyFOKhintNCT03693729

Effects of Brain-stimulation on Metamemory Monitoring and Control

A study testing HD-tDCS in people with Healthy, run by Brooklyn College of the City University of New York at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

When people learn and remember information, it is often accompanied by a feeling of subjective confidence about whether or not information has been learned and accurately remembered. These subjective feelings of confidence are often related to actual memory performance, but are sometimes incorrect. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
HD-tDCS
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
216 participants
Where
1 siteUnited States
Study dates
3 Sep 2018to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy, right-handed adults ages 18-35. English spoken since age 5. Normal or corrected-to-normal vision.

Who cannot join

  • Participants will be excluded if they have chronic skin disease or a medical skin condition, or an unhealed open wound on the scalp, face, neck, or forehead near the electrode location.
  • Participants will be excluded if they self-report significant medical, neurological, or psychiatric illness and/or a history of substance abuse

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Brooklyn College

    Brooklyn, New York, 11210

Other trials in United States

About this study

Official title: Effects of Brain-stimulation on Memory and Memory Awareness

When people learn and remember information, it is often accompanied by a feeling of subjective confidence about whether or not information has been learned and accurately remembered. These subjective feelings of confidence are often related to actual memory performance, but are sometimes incorrect. The investigators have previously shown that applying high definition transcranial direct current stimulation (HD-tDCS) over the dorsolateral prefrontal cortex leads to more accurate feelings of subjective confidence, at least when subjects are asked for their confidence about future memory performance. Accurate confidence judgments are useful in that they may later subsequent behavior, and inaccurate ones may be costly. For example, a student who erroneously believes that studied material was learned may stop studying and not do well on a test. Individuals who have a feeling-of-knowing about the answer to a general knowledge question will continue to search their memory, whereas individuals who do not have a feeling-of-knowing will stop searching their memory. Individuals who are confident they know the answer to a question are more likely to answer it. In this study, the experimenters are testing the effects of brain stimulation on subjective awareness of memory (termed metamemory monitoring) and how people use those subjective judgments (termed metamemory control). The approach taken is to have participants visit the laboratory on 3 visits and receive brain stimulation while completing memory and metamemory tasks.

Conditions
Healthy
Being tested
HD-tDCS
Keywords
memory, metacognition, metamemory, transcranial direct current stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HD-tDCSDevice

    Also called Behavioral

    Participants will complete a metamemory and memory task

Study groups in NCT03693729
Study groupRoleWhat they receive
Active DLPFC during taskExperimentalHD-tDCS will be applied over the DLPFC at 2mA in a single session for up to 30 min during the memory and metamemory task
Receives: Device: HD-tDCS
Active DLPFC after taskActive comparatorHD-tDCS will be applied over the DLPFC at 2mA in a single session for up to 30 min after the memory and metamemory task and during a filler task.
Receives: Device: HD-tDCS
Sham DLPFC during taskSham comparatorSham HD-tDCS will be applied over the DLPFC at 2mA in a single session for up to 30 min during the memory and metamemory task
Receives: Device: HD-tDCS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Memory Control Advantage Index

    This indexes the memory advantage for choosing which general knowledge question one receives a hint about the answer to versus having the experimenter choose which general knowledge question one receives a hint about the answer. The investigators will subtract the proportion of correctly recognized general knowledge answers for experimenter-chosen questions from the proportion correctly recognized for participant-chosen questions

    Measured: Through study completion, an average of 3 weeks

Secondary outcomes (3)
  1. semantic recognition as assessed by a general knowledge task

    Differences in recognition are compared between each condition (each active HD-tDCS and sham).

    Measured: Through study completion, an average of 3 weeks

  2. semantic recall as assessed by a general knowledge task

    Differences in recall are compared between each condition (each active HD-tDCS and sham).

    Measured: Through study completion, an average of 3 weeks

  3. Feeling-of-knowing ratings and their accuracy

    Feeling of knowing ratings are given on a scale. To assess the accuracy of these ratings, the subjective ratings are compared to objective accuracy, using signal detection based measures. Differences in feeling-of-knowing ratings and their accuracy are compared between each condition (each active HD-tDCS and sham).

    Measured: Through study completion, an average of 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2018
  2. Study start3 Sep 2018
  3. Primary completion30 Jun 2022 (estimated)
  4. Study completion30 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
216 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03693729
Sponsor's protocol ID
BrooklynC
Other IDs
SC3GM121192
Acronym
FOKhint
Status last verified
Jul 2020
First submitted
21 Sep 2018
Last updated
10 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing HD-tDCS in people with Healthy, run by Brooklyn College of the City University of New York at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Memory Control Advantage Index (time frame: Through study completion, an average of 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in